pharmaphorum | News & views on pharma and biotech’s evolving …
2 days ago · pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
BioNTech buys Biotheus and its Keytruda rival for $950m
14 hours ago · BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid tumours." It is paying $800 million to acquire all of Biotheus' issued ...
The evolving role of AI in drug submission and approval: An expert ...
2 days ago · The evolving role of AI in drug submission and approval: An expert perspective. Artificial intelligence (AI) is transforming the pharmaceutical industry, revolutionising drug discovery and ...
Pills and polls: What the 2024 election means for pharma
Oct 31, 2024 · At a memorable session at BIO this year, noted pollster Neil Newhouse shared that only 18% of Americans say they approve of the pharmaceutical industry, and 83% believe the number one factor ...
News | Timely industry updates for pharma and biotech leaders
Implementing Corporate & Regulatory-Guided EHS Practices to Achieve Zero Biosafety, Ergonomic & Chemical Incidents for Employee Safety Across Global Facilities. pharmaphorum’s news coverage ...
pharmaphorum - The Deep Dive Digital Magazine has fresh …
Feb 28, 2024 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, Research Partnership, PurpleLeaf Strategy, M3, and more
Pharma in the age of acceleration - pharmaphorum
Disruptive Technologies | Pharma in the age of acceleration. Digital therapeutics present the industry with a unique source of digital disruption. Voice-activated technology is moving from the consumer realm towards the provision of digital biomarkers. Partnerships will be key to ensuring pharma makes the most of data-driven health insights.
Deep Dive: Patients & Partnerships 2024 | pharmaphorum
Nov 6, 2024 · Read Deep Dive: Patients & Partnerships in full pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for ...
The Ozempic dilemma: Balancing demand, supply, and patient …
The sudden and overwhelming demand for GLP-1 agonists, like Ozempic and Wegovy, has placed immense pressure on pharmaceutical supply chains. What started as a treatment for type 2 diabetes has ...
Deep-Dive | pharmaphorum
4 days ago · By inverting the leadership pyramid and putting patients first, we can chart a course toward a healthier, more equitable future, regardless of the political landscape. For all this, and much more ...